Genomics Meets Big Pharma: How Drug Companies are Betting on Pharmacogenomics
The advent of pharmacogenomics in drug development heralds a paradigm shift within the pharmaceutical sector. This evolution is driven by the increasing prominence…
Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Lessons from COVID-19: Pharmacogenomics in Preparing for Future Pandemics
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
End of content
End of content